Florida State University researchers are giving oncologists another tool in their fight against pediatric brain cancer.

In work published in Bioactive Materials, a research team led by Department of Chemistry and Biochemistry Professor Qing-Xiang “Amy” Sang showed the possibility of enhancing natural killer immune cells to improve their ability to attack a rare pediatric brain cancer.

”Natural killer cells are the policemen of the body,” Sang said. “They patrol the body and recognize viruses, bacteria and other pathogens, as well as cancer cells. Our goal is to enhance both the quantity and quality of these cells, making them more potent in their ability to combat cancer.”

Natural killer cells can target all types of cancer, and previous research has examined their effectiveness as a therapy. But this is the first study to test the ability of natural killer cells to destroy a specific variety of cancer known as a malignant rhabdoid tumor. When this tumor appears in the central nervous system, it is called an atypical teratoid rhabdoid tumor (ATRT). Although it is a rare disease, it accounts for 20% of all central nervous system tumors in children younger than 3.

Source: FSU researchers show potential of new treatment for pediatric brain cancer

Facebook
Twitter
LinkedIn
Connect With Us
BraveHearts for Kids Illinois
1879 N. Neltnor Blvd., Suite 105
West Chicago, IL 60185
630-473-4032
Join Our Email List
Receive news, research and event information.
© 2008- 2024 BraveHearts for Kids | Legal Notice and Privacy Policy
IRS Approved 501 (c) 3 Public Charity EIN 270660252